期刊
HUMAN MOLECULAR GENETICS
卷 20, 期 11, 页码 2091-2102出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddr091
关键词
-
资金
- NIH NIA [KO1 AG30378]
Intraneuronal amyloid-beta (A beta) may contribute to extracellular plaque deposition, the characteristic pathology of Alzheimer's disease (AD). The E3-ubiquitin ligase parkin ubiquitinates intracellular proteins and induces mitophagy. We previously demonstrated that parkin reduces A beta levels in lentiviral models of intracellular A beta. Here we used a triple transgenic AD (3xTg-AD) mouse, which over-expresses APP(Swe), Tau(P301L) and harbor the PS1(M146V) knock-in mutation and found that lentiviral parkin ubiquitinated intracellular A beta in vivo, stimulated beclin-dependent molecular cascade of autophagy and facilitated clearance of vesicles containing debris and defective mitochondria. Parkin expression decreased intracellular A beta levels and extracellular plaque deposition. Parkin expression also attenuated caspase activity, prevented mitochondrial dysfunction and oxidative stress and restored neurotransmitter synthesis. Restoration of glutamate synthesis, which was independent of glial-neuronal recycling, depended on mitochondrial activity and led to an increase in g-amino butyric acid levels. These data indicate that parkin may be used as an alternative strategy to reduce A beta levels and enhance autophagic clearance of A beta-induced defects in AD. Parkin-mediated clearance of ubiquitinated A beta may act in parallel with autophagy to clear molecular debris and defective mitochondria and restore neurotransmitter balance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据